Clinical Trial

JOURNEY LVAD: JOURNEY Left Ventricular Assist Device

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to assess the safety and effectiveness of the J-Valve Transfemoral Transcatheter Heart Valve System in patients on left ventricular assist device (LVAD) support with significant native aortic valve regurgitation (AR).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-22.
Status change: Withheld → Not Yet Recruiting 2026-03-03
Trial Details
NCT Number NCT07363473
Lead Sponsor JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
Conditions Aortic Valve Regurgitation, Aortic Valve Disease Mixed, Aortic Insufficiency
Enrollment 50 participants
Start Date 2026-04
Primary Completion 2027-11 (estimated)
Study Completion 2029-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-05